day 3

saturday, SEPTEMBER 8th

8:45am | The End of Alzheimer's Part 1: Uncovered Causes

DALE BREDESEN, MD
The cause(s) of Alzheimer’s disease have remained incompletely defined, although risk factors such as type 2 diabetes and the epsilon-4 allele of the Apolipoprotein E gene (ApoE4) have been described. Precision medicine approaches have proven valuable for the evaluation and treatment of various malignancies. This presentation will review the metabolic profiling done by Dr. Bredesen and his team in patients with Alzheimer’s disease and pre-dementia conditions.

10:45am | The End of Alzheimer's Part 2: Effective Treatment Strategies

DALE BREDESEN, MD
This presentation will pick up where Dr. Bredesen’s first presentation ended, reviewing various treatment approaches taken by Dr. Bredesen and his team with their Alzheimer’s patients, showing the results in several cases.

1:15pm | It Might Be Mold, Now What? Tackling Mold Toxicity in Mental Health

ANN SHIPPY, MD
In this presentation, you’ll find out when to consider mold as an underlying cause of a variety of symptoms, how to test for it and diagnose it, and you’ll learn about important aspects of treatment from case studies of patients who have fully recovered.

1:15pm | Small Intestine Bacterial Overgrowth: Causes, Treatments, and Clinical Consideratrions in Mental Health

KURT WOELLER, DO
Small intestine bacterial overgrowth (SIBO) is a condition where normal colonic bacteria over-populate the small intestine causing excess hydrogen and methane gas production leading to digestive and other problems. Many people with SIBO experience not only physical symptoms with SIBO, but also mental health challenges like anxiety and depression. This presentation will discuss the role of SIBO in chronic health problems, including causes, testing, and intervention.

3:15pm | The Thyroid Axis from A-Z: Understanding, Testing, Interpreting, and Treating

LOUIS CADY, MD
This presentation will review the basic concepts of understanding the thyroid axis as well as the optimal tests which provide the most clarity. Mechanistic reasons will be presented for optimizing the thyroid axis, above and beyond the decades-old strategy of “T3 Augmentation for Depression.” Finally, a step by step way to prescribe and treat subtle (as well as not so subtle) thyroid abnormalities will be reviewed.

3:15pm | Psychiatric Uses of Cannabidiol (CBD)

HYLA CASS, MD
With increasing liberalization of its legal status throughout the U.S. and Canada, cannabis is becoming more readily available as a therapeutic agent. There is increasing information - and some confusion as well - about the therapeutic uses of its “non-high” conferring component, CBD, in treating psychiatric conditions such as anxiety, addiction, PTSD, and dementia. We will discuss the science, case examples, and the role of "THC-free CBD" in these conditions.